Technology Insight: calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease
- 1 February 2005
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Clinical Practice Gastroenterology & Hepatology
- Vol. 2 (2), 96-102
- https://doi.org/10.1038/ncpgasthep0094
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Rectal Nitric Oxide Gas and Stool Cytokine Levels during the Course of Infectious GastroenteritisClinical and Vaccine Immunology, 2004
- Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel diseaseScandinavian Journal of Gastroenterology, 2004
- Fecal Lactoferrin Is A Sensitive and Specific Marker in Identifying Intestinal InflammationAmerican Journal Of Gastroenterology, 2003
- Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy childrenActa Paediatrica, 2002
- Rectal Nitric Oxide Assessment in Children with Crohn Disease and Ulcerative Colitis. Indicator of Ileocaecal and Colorectal AffectionScandinavian Journal of Gastroenterology, 2001
- A simple method for assessing intestinal inflammation in Crohn's diseaseGut, 2000
- Review article: the potential role of nitric oxide in chronic inflammatory bowel disordersAlimentary Pharmacology & Therapeutics, 1999
- Review article: quantitative leucocyte scanning in the assessment of inflammatory bowel disease activity and its response to therapyAlimentary Pharmacology & Therapeutics, 1996
- Greatly increased luminal nitric oxide in ulcerative colitisThe Lancet, 1994
- Clinical Remission in Crohn’s Disease – Assessment Using Faecal 111ln Granulocyte ExcretionDigestion, 1986